Nomura Holdings
GOSS icon

Nomura Holdings’s Gossamer Bio GOSS Stock Holding History

Nomura Holdings’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,000
Closed -$25.1K – 1864
2025
Q4 		$49.6K Buy
+16,000
New +$45.7K ﹤0.01% 1856
2024
Q3 		– Sell
-40,000
Closed -$36K – 1719
2024
Q2 		$36K Buy
+40,000
New +$29.9K ﹤0.01% 1710
2021
Q2 		– Sell
-74,000
Closed -$684K – 2142
2021
Q1 		$684K Sell
74,000
-8,400
-10% -$84.7K ﹤0.01% 1239
2020
Q4 		$800K Buy
82,400
+5,201
+7% +$51.2K ﹤0.01% 1102
2020
Q3 		$951K Buy
+77,199
New +$1.02M ﹤0.01% 835

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Nomura Holdings's GOSS Position: Q1 2026 in Review

Nomura Holdings sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 16,000 shares — an estimated $25.1K sold.

Nomura Holdings first reported a position in GOSS in Q3 2020 and held it in 5 quarters. The position peaked at $951K in Q3 2020. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Nomura Holdings reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 16,000 Gossamer Bio shares in Q1 2026, an estimated $25.1K.
  • Nomura Holdings first reported a position in Gossamer Bio in Q3 2020 and held it in 5 quarters.
  • Nomura Holdings's Gossamer Bio position peaked at $951K in Q3 2020.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.